Selvita Sp. z o.o.

Selvita is a product and solution provider for the pharmaceutical and biotechnology industry from Krakow, Poland. We deliver comprehensive solutions to customers from the pharmaceutical and biotechnology industry targeted at lowering the cost of introducing innovative compounds to the market.The areas of our activity include: * target-based solutions – advanced protein modelling solutions * drug discovery – custom in silico library construction * lead generation – optimization of lead compounds * contract synthesis and syntheses paths optimization * information technology for research projectsSelvita develops its own innovative drugs, which originate from research at Polish universities and later out-licenses them to the customers from the pharmaceutical industry. Selvita is involved in the research projects up to the pre-clinical stage. Our current projects are in the area of oncology, central nervous system, infections and diagnostics. In future we will also be involved in projects in other therapeutic areas. Selvita is also involved in Gencron j.v. which offers services covering the optimum match of genetically identified patient groups to oncology drugs, which are currently under clinical and pre-clinical development (so called drug targeting) but also drugs which failed to achieve the expected milestones during their development cycle (drug repositioning).